Getting clinical trial results into practice: Design, implementation, and process evaluation of the ALLHAT Dissemination Project

Clinical Trials

Volumn 6, Issue 4, 2009, Pages 329-343

  Bartholomew, L Kay ^a   Cushman, William C ^b   Cutler, Jeffrey A ^c   Davis, Barry R ^a   Dawson, Glenna ^a   Einhorn, Paula T ^c   Graumlich, James F ^d   Piller, Linda B ^a   Pressel, Sara ^a   Roccella, Edward J ^c   Simpson, Lara ^a   Whelton, Paul K ^e   Williard, Angela ^f  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ACCESS TO INFORMATION; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG FORMULARY; EVALUATION RESEARCH; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEALTH CARE PLANNING; HEALTH INSURANCE; HEART INFARCTION; HUMAN; HYPERTENSION; INFORMATION DISSEMINATION; INTERNET; MASS MEDIUM; METHODOLOGY; PRACTICE GUIDELINE; PRESCRIPTION; PRETEST POSTTEST DESIGN; PRIORITY JOURNAL; PUBLIC HEALTH; QUASI EXPERIMENTAL STUDY; TREATMENT OUTCOME; BLOOD PRESSURE; CLINICAL TRIAL (TOPIC); INFORMATION PROCESSING; PROCEDURES; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUESTIONNAIRE; STATISTICAL ANALYSIS; UNITED STATES;

BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DISTRICT OF COLUMBIA; EVIDENCE-BASED MEDICINE; FEASIBILITY STUDIES; HUMANS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUESTIONNAIRES;

EID: 70449709213     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774509338234     Document Type: Article

References (80)

1. Woolf SH The meaning of translational research and why it matters. JAMA 2008; 299: 211-13.
2. Majumdar SR, McAlister FA, Furberg CD From knowledge to practice in chronic cardiovascular disease: A long and winding road. J Am Coll Cardiol 2004; 43: 1738-42.
3. Lenfant C. Shattuck lecture-clinical research to clinical practice-lost in translation? N Engl J Med 2003; 349: 868-74.
4. Thomson O. O'Brien MA, Oxman AD, Haynes RB et al. Local opinion leaders: effects on professional practice and health care outcomes [update in Cochrane Database Syst Rev. 2007: CD000125; PMID: 17253445]. Cochrane Database of Systematic Reviews 2000: 000125.
5. Majumdar SR, McAlister FA, Soumerai SB Synergy between publication and promotion: Comparing adoption of new evidence in Canada and the United States. Am J Med 2003; 115: 467-72.
6. Ockene JK, Zapka JG Provider education to promote implementation of clinical practice guidelines. Chest 2000; 118: 33S-39S.
7. Maynard A. Evidence-based medicine: An incomplete method for informing treatment choices. Lancet 1997; 349: 126-8.
8. Fischer PM Evidentiary medicine lacks humility. J Fam Pract 1999; 48: 345-46.
9. Vinker S., Nakar S., Rosenberg E. et al. Attitudes of Israeli family physicians toward clinical guidelines. Arch Fam Med 2000; 9: 835-40.
10. Bero LA, Grilli R., Grimshaw JM et al. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings: The Cochrane Effective Practice and Organization of Care Review Group. BMJ 1998; 317: 465-68.
11. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997; 157: 408-16.
12. Davis DA, Thomson MA, Oxman AD, Haynes RB Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700-05.
13. Lamas GA, Pfeffer MA, Hamm P. et al. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. N Engl J Med 1992; 327: 241-7.
14. Holloway RG, Benesch C., Rush SR Stroke prevention: Narrowing the evidence-practice gap. Neurology 2000; 54: 1899-906.
15. VA Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202: 1028-34.
16. VA Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114mmHg. JAMA 1970; 213: 1143-52.
17. Hypertension Detection and Follow-Up Program Cooperative Research Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562-71.
18. SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
19. Rodriguez T., Malvezzi M., Chatenoud L. et al. Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart 2006; 92: 453-60.
20. Thom TJ, Roccella EJ Trends in blood pressure control and mortality. In: Izzo J, Black HR. (eds). Hypertension Primer: The Essentials of High Blood Pressure. American Heart Association, Dallas, 1999, pp. 268-70.
21. National Center for Health Statistics. Healthy People 2000 Final Review. National Center for Health Statistics, Hyattsville, MD, 2001.
22. Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-97.
23. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet: DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.
24. Gershlick AH, Stephens-Lloyd A., Hughes S. et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005; 353: 2758-68.
25. Einhorn P. NHLBI-initiated program "Interventions to Improve Hypertension Control Rates in African Americans": Background and implementation. Circ Cardiovasc Qual Outcomes 2009; 2: 236-40.
26. Green BB, Cook AJ, Ralston JD et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: A randomized controlled trial. JAMA 2008; 299: 2857-67.
27. Davis BR, Cutler JA, Gordon DJ et al. Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Research Group. Am J Hypertens 1996; 9: 342-60.
28. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000; 283: 1967-75.
29. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-97.
30. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy: Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2003; 42: 239-46.
31. Stafford RS, Monti V., Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension 2006; 48: 213-18.
32. Austin PC, Mamdani MM, Tu K., Zwarenstein M. Changes in prescribing patterns following publication of the ALLHAT trial. JAMA 2004; 291: 44-5.
33. Bartholomew LK, Parcel GS, Kok G., Gottlieb N. Planning Health Promotion Programs: An Intervention Mapping Approach (2 nd edn). Jossey-Bass, San Francisco, 2006.
34. Bartholomew LK, Parcel GS, Kok G. Intervention mapping: A process for developing theory- and evidence-based health education programs. Health Educ Behav 1998; 25: 545-63.
35. Fernandez ME, Gonzales A., Tortolero-Luna G. et al. Using intervention mapping to develop a breast and cervical cancer screening program for Hispanic farm-workers: Cultivando La Salud. Health Promot Pract 2005; 6: 394-404.
36. Morgenstern LB, Bartholomew LK, Grotta JC et al. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med 2003; 163: 2198-202.
37. Morgenstern LB, Staub L., Chan W. et al. Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project. Stroke 2002; 33: 160-66.
38. Scalise D. Physician supply 2005. Hosp Health Netw 2005; 79: 59-65.
39. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Prentice Hall, Inc., Englewood Cliffs, NJ, 1986.
40. Bandura A. Self-efficacy: The Exercise of Control. W.H. Freeman & Co., New York, 1997.
41. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
42. Cabana MD, Rand RS, Powe NR et al. Why don't physicians follow clinical practice guidelines?: A framework for improvement. JAMA 1999; 282: 1458-65.
43. Grol R., Grimshaw J. From best evidence to best practice: Effective implementation of change in patients' care. Lancet 2003; 362: 1225-30.
44. Simon SR, Majumdar SR, Prosser LA et al. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: A cluster-randomized controlled trial. Am J Med 2005; 118: 521-8.
45. Thomson O. O'Brien MA, Oxman AD, Davis DA et al. Educational outreach visits: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000: CD000409.
46. McAlister FA, Fradette M., Graham M. et al. A randomized trial to assess the impact of opinion leader endorsed evidence summaries on the use of secondary prevention strategies in patients with coronary artery disease: The ESP-CAD trial protocol [NCT00175240]. Implementation Sci 2006; 1: 11.
47. U.S. Department of Health and Human Services. JNC 7 Express. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2003; 03 - 5233.
48. Glasgow RE, Vogt TM, Boles SM Evaluating the public health impact of health promotion interventions: The RE-AIM framework. Am J Public Health 1999; 89: 1322-7.
49. Linnan L., Steckler A. Process evaluation for public health interventions and research. In: Steckler A, Linnan L. (eds). Process Evaluation for Public Health Interventions and Research: An Overview. Josey-Bass, San Francisco, 2002, pp. 1-23.
50. Col NF, McLaughlin TJ, Soumerai SB et al. The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study. Arch Intern Med 1996; 156: 54-60.
51. Stafford RS, Singer DE National patterns of warfarin use in atrial fibrillation. Arch Intern Med 1996; 156: 2537-41.
52. Wang TJ, Stafford RS, Ausiello JC, Chaisson CE Randomized clinical trials and recent patterns in the use of statins. Am Heart J 2001; 141: 957-63.
53. Fineberg HV Clinical evaluation: How does it influence medical practice? Bull Cancer 1987; 74: 333-46.
54. Kudesia R., Chaturvedi S. Practice variation among Michigan neurologists in the use of intravenous heparin. J Neurol Sci 2002; 202: 25-7.
55. Petitti DB, Xie F., Barzilay JI Prescribing patterns for thiazide diuretics in a large health maintenance organization: Relationship to participation as an ALLHAT clinical center. Contemp Clin Trials 2006; 27: 397-403.
56. Omoigui NA, Silver MJ, Rybicki LA et al. Influence of a randomized clinical trial on practice by participating investigators: Lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators. J Am Coll Cardiol 1998; 31: 265-72.
57. Muntner P., Krousel-Wood M., Hyre AD et al. Antihypertensive Prescriptions for Newly Treated Patients Before and After the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Guidelines. Hypertension 2009; 53: 617-23.
58. Thomson O. O'Brien M., Freemantle N., Oxman A. et al. Continuing education meetings and workshops. (Systematic review). Cochrane Effective Practice and Organisation of Care Group Cochrane Database of Systematic Reviews, 4 2004.
59. Marinopoulos S., Dorman T., Ratanawongsa N. et al. Effectiveness of Continuing Medical Education. Evidence Report/Technology Assessment No. 149 (Prepared by the Johns Hopkins Evidence-based Practice Center, under Contract No. 290-02-0018). 2007; AHRQ Publication No. 07 - E006.
60. Goldstein MK, Lavori P., Coleman R. et al. Improving adherence to guidelines for hypertension drug prescribing: Cluster-randomized controlled trial of general versus patient-specific recommendations. Am J Manag Care 2005; 11: 677-85.
61. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA 1990; 263: 549-56.
62. Balas EA, Boren SA, Griffing G. Computerized management of diabetes: A synthesis of controlled trials. Proceedings of the AMIA Symposium 1998; 295-99.
63. Krishna S., Balas EA, Spencer DC et al. Clinical trials of interactive computerized patient education: Implications for family practice. J Fam Pract 1997; 45: 25-33.
64. Shea S., DuMouchel W., Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc 1996; 3: 399-409.
65. Grilli R., Ramsay C., Minozzi S. Mass media interventions: Effects on health services utilisation. Cochrane Database of Systematic Reviews 2002; Issue 1. Art. No.: CD000389. DOI: 10.1002/14651858.CD000389.
66. Smith W. Evidence for the effectiveness of techniques to change physician behavior. Chest 2000; 118: 8S-17S.
67. Clark NM, Gong M. Management of chronic disease by practitioners and patients: Are we teaching the wrong things? BMJ 2000; 320: 572-75.
68. Stone EG, Morton SC, Hulscher ME et al. Interventions that increase use of adult immunization and cancer screening services: A meta-analysis. Ann Intern Med 2002; 136: 641-51.
69. Bloom BS Effects of continuing medical education on improving physician clinical care and patient health: A review of systematic reviews. Int J Technol Assess Health Care 2005; 21: 380-5.
70. Grindrod KA, Patel P., Martin JE What interventions should pharmacists employ to impact health practitioners' prescribing practices? Ann Pharmacother 2006; 40: 1546-57.
71. Yokoyama K. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy. J Managed Care Pharm 2007; 13: 235-44.
72. Olson BM Approaches to pharmacy benefit management and the impact of consumer cost sharing. Clin Therap 2003; 25: 250-72.
73. Goldman DP, Joyce GF, Escarce JJ et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 2004; 291: 2344-50.
74. National Heart, Lung, and Blood Institute, the National Institutes of Health. Landmark Hypertension Treatment Study Launches Extensive Physician and Patient Education Program to Improve Public Health (Press release, February 1, 2006).
75. Rosamond W., Flegal K., Friday G. et al. Heart disease and stroke statistics 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Committee. Circulation 2007; 115: E69-171.
76. Pollak A. The minimal impact of a big hypertension study. The New York Times, 2008 Nov 27; Sec B;1 (New York edition).
77. Davis BR, Furberg CD, Wright Jr JT et al., for the ALLHAT Collaborative Research Group. ALLHAT: Setting the record straight. Ann Intern Med 2004; 141: 39-46.
78. Davis BR, Piller LB, Cutler JA et al. Role of diuretics in the prevention of heart failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2006; 113: 2201-10.
79. Rogers EM Diffusion of Innovations (5 th edn). Free Press, New York, 2003.
80. Woolf SH The meaning of translational research and why it matters. JAMA 2008; 299: 211-13.